14 October 2024

A major project has been launched aimed at finding ways of studying blood and immune system as it is produced within the bone marrow.

More than US$8 million has been invested in the California-based project by the US National Institutes of Health.

The project will use a technology called MEMOIR, developed at Caltech, the research university in California, USA.

MEMOIR - Memory by Engineered Mutagenesis with Optical In situ Readout - uses advanced microscopy to record the history of cells in situ. Scientists have been seeking to develop “family trees” of cells to understand the environment in which they develop. The researchers now hope to link cell to cell interactions of haematopoietic stem and progenitor cells (HSPCs), studying how they proliferate and differentiate.

Researcher Professor Michael Elowitz, of Caltech, said: “We’re excited to apply these new technologies to study the complex interactions of HSPCs within the context of their native environment in the bone marrow.”

Fellow researcher Dr Rong Lu, of the University of Southern California, said: “This research will provide unprecedented insights into how spatial context might determine which HSPCs are dominant in producing blood and immune cells. These insights have the potential to advance our understanding of the diseases that can develop when some HSPCs become too dominant, such as leukaemia, as well as to guide efforts to improve bone marrow transplantation.”

 

Source: University of Southern California

Link: https://stemcell.keck.usc.edu/uscs-rong-lu-and-caltechs-michael-b-elowitz-win-the-nih-directors-transformative-research-award/

Disclaimer: The news stories shared on this site are used as a way to inform our members and followers of updates and relevant information happening in Haematology. The BSH does not endorse the content of news items from external sources, and is not in a position to verify the findings, accuracy or the source of any studies mentioned. Any medical or drugs information is provided as an information resource only, and is not to be relied on for any diagnostic or treatment purposes.

News service provided by Englemed News.